A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy
Conditions: Hepatic Carcinoma Interventions: Drug: Ga-68 Dolacga Injection Sponsors: National Atomic Research Institute, Taiwan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Proton Therapy | Research | Study | Taiwan Health | Urology & Nephrology